Ravi Viswanathan, 10% Owner at RHYTHM PHARMACEUTICALS, INC. (RYTM), bought 1,952,870 shares at $17.00 ($9.3M) on 2017-10-10, disclosed to the SEC on 2017-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,402,870 | $0 | 0.0% |
| 2 | $17.00 | 550,000 | $9.3M | 100.0% |
| Total | $4.79 avg | 1,952,870 | $9.3M | 100% |
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |